Demo Sign up Log In

AgeX Therapeutics, Inc. (AGE)

EV/EBITDA

-0.22×

TTM · Retrieved: Oct 25, 2026

AGE EV/EBITDA

Current (TTM)-0.22×retrievedOct 25, 2026

Current (TTM)-0.22×retrievedOct 25, 2026

AGE Quarterly EV/EBITDA (0.00× → -1.62×)

Latest values, visible window

High-resolution chart · PNG

AGE ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. EV/EBITDA — Quarterly
Period ending	EV/EBITDA
Jun 30, 2026	-1.6185×
Mar 31, 2026	-0.2852×
Dec 31, 2025	-6.3142×
Sep 30, 2025	-10.9329×
Jun 30, 2025	-8.6638×
Mar 31, 2025	-10.6715×
Dec 31, 2024	-15.2816×
Sep 30, 2024	46.3885×
Jun 30, 2024	14.5653×
Mar 31, 2024	-2.4057×
Dec 31, 2023	8.8502×
Sep 30, 2023	28.8652×
Jun 30, 2023	71.9846×
Mar 31, 2023	31.4882×
Dec 31, 2022	-22.1535×
Sep 30, 2022	-24.8879×
Jun 30, 2022	-20.4494×
Mar 31, 2022	-27.7876×
Dec 31, 2021	-29.8278×
Sep 30, 2021	-28.5555×
Jun 30, 2021	-31.4101×
Mar 31, 2021	-39.9621×
Dec 31, 2020	-28.5239×
Sep 30, 2020	-17.3069×
Jun 30, 2020	-16.5338×
Mar 31, 2020	-12.7755×
Dec 31, 2019	-28.7674×
Sep 30, 2019	-24.2408×
Jun 30, 2019	-42.2092×
Mar 31, 2019	-40.2774×
Dec 31, 2018	-32.6783×
Sep 30, 2018	-43.9796×
Jun 30, 2018	-47.5744×
Mar 31, 2018	-452.6953×
Dec 31, 2017	-64.2927×
Sep 30, 2017	0×
Jun 30, 2017	0×
Mar 31, 2017	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.